Real-World Use and Impact of Direct Oral Anticoagulants in Cardioembolic Stroke Patients with Atrial Fibrillation
Preprint
- 27 October 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background and Objectives: Atrial fibrillation (AF) is a primary cause of cardioembolic stroke (CS). AF-related mortality increased substantially in Eastern Europe in the last decade. While direct oral anticoagulants (DOACs) are effective for stroke prevention, non-adherence is a major clinical problem. This study aimed to investigate real-world DOAC usage among AF patients presenting with stroke and to evaluate the impact of prior DOAC therapy on stroke severity. Materials and Methods: This retrospective study analysed data from CS patients with AF admitted to the two largest Latvian university hospitals from January 2022 to December 2024. Secondly, a propensity-matched analysis was performed on a single-centre cohort to compare outcomes between patients receiving DOAC therapy and those not. Results: Of 2773 patients enrolled, the largest subgroup (45%) consisted of patients with known AF who were not on appropriate anticoagulation therapy before the stroke event. The propensity-matched analysis based on demographics, arrival time, AF type, and CHA 2 DS 2 -VA score (163 patients per group) revealed that patients taking DOACs presented with significantly milder strokes than non-users (mean admission NIHSS: 9.8 vs. 11.6, p=0.009). 40.5% of DOAC users received a reduced DOAC dose, and in 22.1% the DOAC dose was reduced inadequately. Stroke patients on DOAC therapy had significantly larger left atrial volume indices (LAVI) than non-users (56.4 vs. 48.0, respectively; p=0.004). Conclusions: Non-adherence to DOACs represents a substantial contributor to the CS burden. Prior DOAC use is associated with significantly reduced initial stroke severity, highlighting the protective benefit of therapy even when it fails to prevent an event.Keywords
All Related Versions
This publication has 27 references indexed in Scilit:
- 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)European Heart Journal, 2024
- Atrial fibrillation burden: a new outcome predictor and therapeutic targetEuropean Heart Journal, 2024
- Trends in atrial fibrillation-related mortality in Europe, 2008–2019European Heart Journal - Quality of Care and Clinical Outcomes, 2024
- Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral AnticoagulantsJAMA Neurology, 2023
- Decline of coronary heart disease mortality is strongly effected by changing patterns of underlying causes of death: an analysis of mortality data from 27 countries of the WHO European region 2000 and 2013European Journal of Epidemiology, 2020
- Early Rhythm-Control Therapy in Patients with Atrial FibrillationNew England Journal of Medicine, 2020
- 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort studyThe Lancet, 2015
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2015
- Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROESEuropean Heart Journal, 2014
- Clinical Classifications of Atrial Fibrillation Poorly Reflect Its Temporal PersistenceJACC, 2014